06:34 EST Dynavax (DVAX) jumps 37% to $15.31 after buyout offer from Sanofi (SNY)
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVAX:
- Sanofi to acquire Dynavax for $15.50 per share in cash, or $2.2B
- Sanofi (SNY) Acquires Dynavax in $2.2 Billion Deal after FDA Rebuff
- Dynavax Technologies Reports Strong Q3 Earnings and Strategic Growth
- Dynavax’s Promising Growth and Strategic Initiatives Justify Buy Rating with $25 Target
- Dynavax reports Q3 EPS 21c vs. 12c last year